Companies

Coya Therapeutics, Inc. (COYA) SEC filings

CIK 0001835022 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)7.9 M6.0 M0
Net income (USD)-21.2 M-8.0 M-12.2 M
Diluted EPS (USD/shares)-1.27-0.79-4.73

Latest filings

FiledFormDescriptionPeriod
2026-10-148-K8-K items 8.012026-10-14
2026-10-058-K8-K items 8.012026-10-05
2026-09-158-K8-K items 8.012026-09-15
2026-08-1110-Q10-Q2026-06-30
2026-08-118-K8-K items 2.02,9.012026-08-11
2026-08-078-K/A8-K/A items 5.022026-03-29
2026-07-27SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-258-K8-K items 5.072026-06-25
2026-05-13ARSARS2025-12-31
2026-05-13DEFA14ADEFA14A
2026-05-13DEF 14ADEF 14A2026-06-25
2026-05-128-K8-K items 1.01,9.012026-05-12
2026-05-12424B5424B5
2026-05-1210-Q10-Q2026-03-31
2026-05-128-K8-K items 2.02,8.01,9.012026-05-12
2026-04-09442026-04-09
2026-04-09332026-04-01
2026-04-028-K8-K items 5.02,9.012026-03-29
2026-03-20EFFECTEFFECT items ,,
2026-03-20424B3424B3
2026-03-19CORRESPCORRESP
2026-03-19UPLOADUPLOAD
2026-03-16S-3S-3
2026-03-1610-K10-K2025-12-31
2026-03-168-K8-K items 2.02,9.012026-03-16

Forms on file (last 1,000): 4 54, 8-K 54, 3 13, 10-Q 11, CORRESP 10, UPLOAD 10, EFFECT 7, SC 13G/A 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=COYA (0.002 USD), /gw/filings/filings?ticker=COYA&form=8-K, /gw/filings/facts?ticker=COYA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange